MSTN / Growth/differentiation factor 8 · Western blot design guide

Design a Western Blot for MSTN

Real validated MSTN Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-MSTN WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use

Western blot protocol sheet for MSTN: expected band ~42.8 kDa, hero antibody M00926, catalog values and labelled standard workflow; separate PMC comparisons on the guide — Printable **MSTN** Western blot protocol sheet — expected band ~42.8 kDa, antibody M00926, controls and PMC citations. Open the full MSTN WB guide →

Navigate to: Protocols Band Controls Antibodies

MSTN Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running

	Expected band	~42.8 kDa
	Gel	15% (standard starting point)
	Negative control ⓘ	Suggested KO / knockdown lysate

Important caveats

Reasons your observed band may differ from the expected size.

	PTM	Glycosylated + Cleaved
	Caveat	Processing-state controls
	Gene-set association	MSigDB C7 membership
	Isoform	1 isoform(s)

Section 1

Real Curated MSTN Western Blot Protocols

The M00926 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysate	Target-positive lysate and matched negative control (standard starting point)
Gel %	15% (standard starting point)
Load	20–30 µg total protein per lane; optimize for abundance (standard starting point)
Transfer	Short semi-dry transfer; verify retention (standard starting point)
Membrane	0.2 µm PVDF (standard starting point)
Blocking	5% milk or 5% BSA in TBST (standard starting point)
Primary antibody	M00926; use the WB datasheet starting dilution (standard starting point)
Primary incubation	Overnight at 4 °C (standard starting point)
Secondary antibody	Species-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation	1 h at room temperature (standard starting point)
Wash	3 × 5 min in TBST (standard starting point)
Detection	ECL; bracket exposures to avoid saturation (standard starting point)

Section 2

What Is the Expected MSTN Western Blot Band Size?

MSTN has a predicted 42.8 kDa precursor; cleavage, Asn71 glycosylation, and disulfide-linked dimerization may affect bands, but their migration is not demonstrated here.

What am I looking at on my blot?
Band near 42.8 kDa	Consistent with the predicted full-length precursor, pending band-identity confirmation
Band below 42.8 kDa	Could reflect signal-peptide or propeptide cleavage; fragment size is not supplied
Band near twice the monomer size under non-reducing conditions	Could reflect the disulfide-linked homodimer
Little or no band in whole-cell lysate	Consistent with secretion of MSTN

💡Expected MSTN appearanceThe full-length MSTN precursor has a predicted mass of 42.8 kDa; cleavage and disulfide-linked dimerization may change the pattern, but no empirical band size is supplied, so confirm identity with appropriate antibody and sample controls.

How each factor affects band size
Predicted full-length mass	42.8 kDa is the sequence-based precursor mass, not a validated Western-blot band
N-linked glycosylation at Asn71	May affect precursor migration, but a visible shift is not established
Disulfide-linked homodimer	May produce a band near twice the relevant monomer size under non-reducing conditions
Signal peptide and propeptide cleavage	Produce shorter forms than the full-length precursor; their apparent masses are not supplied

Why is my band missing or off?
Situation	Likely cause	Next action
No band in lysate	MSTN is secreted	Examine conditioned medium alongside lysate
Band higher than expected	A disulfide-linked homodimer may persist with incomplete reduction	Compare reducing and non-reducing samples
Band lower than expected	Signal-peptide or propeptide cleavage may yield shorter forms	Compare antibodies recognizing precursor and mature regions
Broad smear instead of sharp band	Variable modification at the N-linked Asn71 site is possible, but a smear is not established	Compare samples before and after N-glycan removal to test that explanation
Multiple bands	Precursor, cleaved forms, and disulfide-linked dimers may coexist	Compare reducing conditions and antibodies to different MSTN regions
Weak or no signal	Secreted MSTN may be scarce in the sampled material	Check conditioned medium and include a suitable positive control

Source: UniProt O14793 Human Protein Atlas product datasheet (M00926)

Experiment evidence

Western blot images showing MSTN band

M00926 · MSTN

A00926-2 · MSTN

← swipe / scroll for more images →

Real WB data behind the band-size expectations in this section.

Sample controls for MSTN Western blot

🧪For positive controls for MSTN in Western blot, you can use a separately validated positive sample; the supplied HPA evidence identifies no positive tissue or cell.

Positive control: No high/medium HPA tissue identified

Negative control: Suggested KO / knockdown lysate

Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.

⚠️Feasibility: MSTN is secreted, so whole-cell lysates may show little signal; consider an extracellular sample.

HPA tissue expression evidence for MSTN

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

Tissue	Cell type	Level	Evidence	Source
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

Tissue	Cell type	Level	Evidence	Source
No lower-expression tissue rows available in the supplied evidence.

Section 3

Advanced MSTN Western Blot Tips

Deeper troubleshooting and optimisation questions for MSTN, answered from its protein features.

How should MSTN band migration be interpreted?

Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.

Could annotated MSTN isoforms explain multiple bands?

Isoforms · The supplied record lists one isoform and no alternative sequence. Do not assign multiple bands to annotated splice isoforms on this evidence. Consider processing, Asn71 glycosylation, and disulfide-linked dimerization when evaluating additional bands.

Can glycosylation affect MSTN migration?

PTM · UniProt lists one N-linked glycosylation site, Asn71, within the propeptide. Compare matched samples with and without deglycosylation if assessing its contribution. Asn71 uses the supplied UniProt precursor numbering; its presence does not establish a visible shift.

Does this guide establish induction of MSTN?

Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.

How should transfer be checked for MSTN?

Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.

How should blocking be optimized?

Blocking · Standard workflow guidance: follow the M00926 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.

How should I quantify secreted MSTN?

Quantitation · MSTN is annotated as secreted. For secreted protein, measure conditioned medium using matched collection conditions and sample volumes. Quantify the same identified band under consistent reducing conditions across samples; precursor, processed products, and disulfide-linked dimers may represent different species.

Why might MSTN bands differ from 42.8 kDa?

Interpretation · 42.8 kDa is the predicted mass of the 375-residue precursor. MSTN has a signal peptide at residues 1–23 and a propeptide at 24–266, so processing may produce smaller species. Glycosylation and disulfide-linked dimerization may also affect migration. These features alone cannot predict an observed band position.

Consider the precursor and products of signal peptide and propeptide processing. The listed signal peptide spans residues 1–23 and the propeptide spans 24–266 in UniProt precursor numbering. Use antibodies with known epitope locations to determine which products they could detect.

MSTN is annotated as a disulfide-linked homodimer, with five disulfide bonds listed. Compare reducing and nonreducing samples when investigating a higher migrating species. A change would support a disulfide-dependent species, but migration alone would not identify the band.

Check whether the antibody recognizes the propeptide or a region after residue 266 in UniProt precursor numbering. Compare reducing conditions for disulfide-linked species and, where relevant, deglycosylation for the Asn71 site. The record provides no empirical band position, so these checks cannot identify a band by size alone.

Boster reagents

MSTN Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western Blot analysis using GDF-8 Monoclonal Antibody against truncated GDF-8-His recombinant protein (1).

Anti-GDF-8 MSTN Mouse Monoclonal Antibody

Cat # M00926

View product →

Real WB data

Western blot analysis of GDF8/Myostatin/MSTN using anti-GDF8/Myostatin/MSTN antibody (A00926-2). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 50ug of sample under reducing conditions. Lane 1: human CACO-2 whole cell lysates, Lane 2: rat skeletal muscle tissue lysates, Lane 3: mouse skeletal muscle tissue lysates. After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-GDF8/Myostatin/MSTN antigen affinity purified polyclonal antibody (Catalog # A00926-2) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for GDF8/Myostatin/MSTN at approximately 50KD. The expected band size for GDF8/Myostatin/MSTN is at 50KD.

Anti-GDF8/Myostatin/MSTN Antibody Picoband®

Cat # A00926-2

View product →

Two the supplier anti-MSTN antibodies have Western blot images. M00926 was shown against truncated recombinant GDF-8-His; A00926-2 was shown with human CACO-2 cell and rat and mouse skeletal muscle lysates, with a band near 50 kDa. These images document the stated samples and conditions.

Which to pick: For human CACO-2 or rat or mouse skeletal muscle lysates, consider A00926-2; its WB image uses those samples at 0.5 μg/mL under reducing conditions. M00926 lists human reactivity, but its WB image uses truncated recombinant protein, so lysate performance is not shown here.

Source: BosterBio MSTN gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.

References

UniProt Consortium. UniProt entry O14793.
Human Protein Atlas. MSTN tissue expression.
PMC4987667 — target-verified WB comparison
PMC8393414 — target-verified WB comparison
PMC11720223 — target-verified WB comparison